These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9654379)

  • 1. Neural dynamics of short and medium-term motor control effects of levodopa therapy in Parkinson's disease.
    Contreras-Vidal JL; Poluha P; Teulings HL; Stelmach GE
    Artif Intell Med; 1998 May; 13(1-2):57-79. PubMed ID: 9654379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa medication improves incidental sequence learning in Parkinson's disease.
    Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
    Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
    Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
    Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder.
    Morris M; Iansek R; McGinley J; Matyas T; Huxham F
    Mov Disord; 2005 Jan; 20(1):40-50. PubMed ID: 15390033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.
    Herz DM; Siebner HR; Hulme OJ; Florin E; Christensen MS; Timmermann L
    Neuroimage; 2014 Apr; 90():15-23. PubMed ID: 24269570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dynamical-systems model for Parkinson's disease.
    Connolly CI; Burns JB; Jog MS
    Biol Cybern; 2000 Jul; 83(1):47-59. PubMed ID: 10933237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries.
    Lewis MM; Slagle CG; Smith AB; Truong Y; Bai P; McKeown MJ; Mailman RB; Belger A; Huang X
    Neuroscience; 2007 Jun; 147(1):224-35. PubMed ID: 17499933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group.
    Growdon JH; Kieburtz K; McDermott MP; Panisset M; Friedman JH
    Neurology; 1998 May; 50(5):1327-31. PubMed ID: 9595982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa Effect on Basal Ganglia Motor Circuit in Parkinson's Disease.
    Gao LL; Zhang JR; Chan P; Wu T
    CNS Neurosci Ther; 2017 Jan; 23(1):76-86. PubMed ID: 27663605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease.
    Yokochi M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S25-30. PubMed ID: 19131038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dynamic model of motor basal ganglia functions.
    Suri RE; Albani C; Glattfelder AH
    Biol Cybern; 1997 Jun; 76(6):451-8. PubMed ID: 9263432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson's disease.
    Miller NS; Kwak Y; Bohnen NI; Müller ML; Dayalu P; Seidler RD
    Behav Brain Res; 2013 Nov; 257():100-10. PubMed ID: 24076152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetrical effect of levodopa on the neural activity of motor regions in PD.
    Martinu K; Nagano-Saito A; Fogel S; Monchi O
    PLoS One; 2014; 9(11):e111600. PubMed ID: 25369523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
    Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
    Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural substrates and potential treatments for levodopa-induced dyskinesias in Parkinson's disease.
    Phillips JR; Eissa AM; Hewedi DH; Jahanshahi M; El-Gamal M; Keri S; Moustafa AA
    Rev Neurosci; 2016 Oct; 27(7):729-738. PubMed ID: 27362959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S;
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test.
    Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Meco G
    Funct Neurol; 2002; 17(4):199-201. PubMed ID: 12675263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.